secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProPhase Labs, Inc. (PRPH)
CIK:        0000868278
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001493152-23-021848
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProPhase Labs stockholders approve equity plan amendments, increase share reserves
--------------------------------------------------------------------------------

- Amended 2022 Equity Compensation Plan approved, increasing share reserve by 700,000 shares.
- Amended 2022 Directors' Equity Compensation Plan approved, increasing share reserve by 150,000 shares.
- All four director nominees elected: Ted Karkus, Jason Barr, Louis Gleckel, MD, Warren Hirsch.
- Ratification of Morison Cogen LLP as independent auditor for fiscal year 2023 approved (15,066,019 for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/868278/000149315223021848/0001493152-23-021848-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/868278/000149315223021848/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-021848

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer